Differences

This shows you the differences between two versions of the page.

--- home:mp:break [05.10.2014] – joyful
+++ home:mp:break [09.14.2022] (current) – external edit 127.0.0.1
@@ Line 5: / Line 5: @@
-The Marshall Protocol (MP) is a curative medical treatment, which allows patients to make progress by activating the innate immune response. In the process, this generates immunopathology. From time to time, patients want to take a break or "vacation" from their immunopathology and process of recovery. For patients who do not care or want to [[home:mp:managing_immunopathology|manage their immunopathology]] using any of the outlined strategies, there is the option to discontinue antibiotics.
+The Marshall Protocol (MP) is a curative medical treatment, which allows patients to make progress by activating the innate immune response by taking olmesartan (Benicar). In the process, this generates immunopathology. Patients will sometimes find it difficult to [[home:mp:managing_immunopathology|manage their immunopathology]]. Patients in later stages of treatment may find their immune response is relatively self-sustaining, and that it will take longer for the immunopathology to stabilize when making adjustments.
-The length of time it takes for antibiotics to no longer have an effect is variable. Determining factors include how long the antibiotics stay in one's system (often a month or more) as well as how self-sufficient the immune system is. Patients in later stages of treatment may find their immune response is relatively self-sustaining, and that it will take longer for the immunopathology to die down.
+For those who have added antibiotics, they may find they need to discontinue the use of antibiotics when the immune response is too strong. The length of time it takes for antibiotics to no longer have an effect is variable. Determining factors include how long the antibiotics stay in one's system (often a month or more) as well as how self-sufficient the immune system is.
 Patients are advised not to discontinue olmesartan (Benicar), as the drug is palliative and protects organs.
@@ Line 39: / Line 39: @@
 So, again, thank you, and do let us know how things are going from time to time.
-p.s., our new MP knowledge base provides links to recent papers, publications, and presentations by our research team that you may find to be of interest... http://mpkb.org/home/publications
+p.s., our new MP knowledge base provides links to recent papers, publications, and presentations by our research team that you may find to be of interest... https://mpkb.org/home/publications
 //**Joyful**, MarshallProtocol.com// </blockquote>
@@ Line 119: / Line 119: @@
 //**John McDonald**, MarshallProtocol.com// </blockquote>
+{{tag>MP}}
+<nodisp>
 ===== Notes and comments =====
@@ Line 127: / Line 130: @@
   * Legacy content
-    * http://www.marshallprotocol.com/view_topic.php?id=1128&forum_id=32&jump_to=39971#p39971 f300
+    * https://www.marshallprotocol.com/view_topic.php?id=1128&forum_id=32&jump_to=39971#p39971 f300
-    * http://www.marshallprotocol.com/forum32/5504.html#p52138 f279
+    * https://www.marshallprotocol.com/forum32/5504.html#p52138 f279
-    * http://www.marshallprotocol.com/forum32/1128.html f299
+    * https://www.marshallprotocol.com/forum32/1128.html f299
+</nodisp>

home/mp/break.1399762252.txt.gz · Last modified: 05.10.2014 by joyful